Hirayama Shigeto, Wada Naohisa, Kuroda Naoya, Iwai Takashi, Yamaotsu Noriyuki, Hirono Shuichi, Fujii Hideaki, Nagase Hiroshi
School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.
School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; International Institute for Integrative Sleep Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Bioorg Med Chem Lett. 2014 Oct 15;24(20):4895-8. doi: 10.1016/j.bmcl.2014.08.012. Epub 2014 Aug 12.
We designed and synthesized of 1,3,5-trioxazatriquinanes with o- or p-hydroxyphenyl rings as analogs of the κ opioid receptor agonist SYK-146 with m-hydroxyphenyl groups. Although almost all tested compounds did not bind to the opioid receptors, only 17b (SYK-524) with two o-hydroxyphenyl rings showed moderate or potent binding affinities and exhibited agonistic activities for the three opioid receptor types. Because the basicity of the nitrogen atom in the 1,3,5-trioxazatriquinane structure was predicted to be very low due to the electron withdrawing effect of the three oxygen atoms, SYK-524 was a novel non-morphinan and nonpeptidic opioid universal agonist lacking a basic nitrogen atom.
我们设计并合成了带有邻羟基苯基或对羟基苯基环的1,3,5-三恶唑并三喹烷,作为带有间羟基苯基的κ阿片受体激动剂SYK-146的类似物。尽管几乎所有测试化合物都不与阿片受体结合,但只有带有两个邻羟基苯基环的17b(SYK-524)表现出中等或强效的结合亲和力,并对三种阿片受体类型均表现出激动活性。由于预测1,3,5-三恶唑并三喹烷结构中的氮原子由于三个氧原子的吸电子作用碱性非常低,SYK-524是一种新型的非吗啡喃和非肽类阿片通用激动剂,缺少碱性氮原子。